Clinical trials
Phase 2/3 trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 4 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Recruiting | 14 |
| Active, not recruiting | 9 |
| Terminated | 8 |
| Enrolling by invitation | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 5 |
| Hoffmann-La Roche | 4 |
| Janssen Research & Development, LLC | 4 |
| University of Auckland, New Zealand | 3 |
| AMO Pharma Limited | 2 |
| AbbVie | 2 |
| Amgen | 2 |
| Ascendis Pharma Growth Disorders A/S | 2 |
| Australasian Gastro-Intestinal Trials Group | 2 |
| Mandos LLC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 5 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Achondroplasia | 2 |
| Alzheimer Disease | 2 |
| Brain Injuries, Traumatic | 2 |
| COVID-19 | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Cognitive Dysfunction | 2 |
| Deglutition Disorders | 2 |
| Dementia | 2 |
Trials
Showing 51 to 74 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.